期刊文献+

系统性红斑狼疮并发肺动脉高压的临床回顾性分析 被引量:10

Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension
下载PDF
导出
摘要 目的分析系统性红斑狼疮(SLE)合并肺动脉高压(PAH)的临床特点,讨论PAH在SLE中的发生率、致病原因以及PAH的相关临床特征,从而提高对SLE继发PAH的认识。方法回顾性分析2001年1月至2007年12月在我院初诊的798例SLE患者中39例经超声心动图诊断明确、资料完整的合并PAH患者。结果本组SLE患者合并PAH的患病率为4.9%,此39例患者年龄14~77岁,平均(33±12)岁,男性5例,女性34例。其中雷诺现象、指端血管炎、抗u1RNP阳性、抗心磷脂抗体IgG阳性、心包积液、SLEDAI评分高和肺间质病变与出现PAH的发生率成正相关。结论SLE是自身免疫性疾病中合并PAH的较常见的疾病,对于出现雷诺现象、指端血管炎、抗u1RNP阳性、抗心磷脂抗体IgG阳性以及心包积液和肺间质病变的SLE患者应警惕PAH的可能,超声心动图及相关检查有利于早期诊断。 Objective To investigate the clinical manifestations, diagnosis and interventions of pulmonary hypertension (PAH) in patients with systemic lupus erythematosus (SLE). Methods From January 2001 to December 2007, 798 SLE patients without prior diagnosis were admitted in our hospital, among whom 39 were identified to have concomitant PAH defined by echocardiography. The clinical data of the 39 cases were analyzed retrospectively. Results The incidence of PAH was 4.9% in these cohort of SLE patients. The 39 SLE patients with concomitant PAH included 5 men and 34 women with a mean age of 34±12 years. Positive correlations were found between the occurrence.ofPAH and the Raynaud phenomenon, fingertip vasculitis, anti-ulRNP antibody positivity, antiphospholipid antibody positivity, pericardial effusion, and interstitial pneumonia (P〈0.05). Patients with higher scores for SLE Disease Activity Index were liable to PAH. The presence of Raynaud phenomenon, fingertip vaseulitis, anti-ulRNP antibody positivity, antiphospholipid antibody positivity, pericardial effusion, and interstitial pneumonia is correlated to greater severity PAH with poor prognosis. Conclusions PAH is not a rare concomitant disease in SLE patients. The presence of Raynaud phenomenon, fingertip vasculitis, anti-ulRNP antibody positivity, antiphospholipid antibody positivity, pericardial effusion, and interstitial pneumonia all suggest the likeliness of PAH in SLE patients, and echocardiographic examination may help derive an early diagnosis.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2008年第10期1860-1863,共4页 Journal of Southern Medical University
关键词 肺动脉高压:系统性红斑狼疮 雷诺现象 pulmonary hypertension systemic lupus erythematosus Raynaud phenomenon
  • 相关文献

参考文献13

  • 1Hochberb MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1997, 40:1725.
  • 2Wallace DJ, Hahn BH. Dubois lupus erythematosus. 5th [M]. Philadephia: Lippincott Williams and Wilkins, 1997:19-30.
  • 3Simonneau G, Galie N, Rubin L J, et al. Clinical classification of pulmonary hypertension [J]. J Am Coil Cardiol, 2004, 43 (Suppl): 5-12.
  • 4British Cardiac Society Guidelines and Medical Practice Committee. Recommendations on the management of pulmonary hypertension in clinical practice[J].Heart, 2001, 86 (Suppl 1): 11-3.
  • 5Horn CA. Pulmonary hypertension and autoimmune disease [J]. Chest, 1993, 104: 279-82.
  • 6Winslow TM, Ossipov MA, Fazio GP, et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus [J]. Am Heart J, 1995, 129 (3): 510-5.
  • 7Joseph PH, Gary WH. Pulmonary complications of collagen vascular disease[J]. Annu Rev Med, 1992, 43: 17-35.
  • 8Richard MS. Clinical problems: scleroderma [J].Rheum Dis Clin North Am, 1996, 22: 825-40.
  • 9Asherson RA, Cervera R. Antiphospholipid antibodies and lung[J]. J Rheumatol, 1995, 22: 62-6.
  • 10陈志营,毕黎琦,赵林阳.结缔组织病与肺动脉高压[J].中国实验诊断学,2003,7(6):551-555. 被引量:14

二级参考文献41

  • 1[1]Stupi AM, Steen VD, Owens GR, et al. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis[J]. Arthritis Rheum, 1986,29:515.
  • 2[2]Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease[J]. Respir Med, 1999,93 (2) :95.
  • 3[3]Winslow TM, Ossipov MA, Fazio GP, et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus[J] .Am Heart J,1995,129 (3): 510.
  • 4[4]Prakash UB. Respiratory complications in mixed connective tissue disease [J]. Clin Chest Med, 1998,19 (4) :733.
  • 5[5]Dawson JK, Goodson NG, Graham DR, et al. Raised pulmonary artery pressures measred with Doppler echocardiography in rheumatoid arthritis patients[J]. Rheumatology (Oxford), 2000,39 (12): 1320.
  • 6[6]Grateau G, Roux ME, Franck N, et al. Pulmonary hypertension in a case of dermatomyositis[ J]. J Rheumatol, 1993,20(8): 1452.
  • 7[7]Sato T, Matsubara O, Tanaka Y, et al. Association of Sjogren' s syndrome with pulmonary hypertension: report of two cases and review of the literature[J]. Hum Pathol, 1993,24 (2):199.
  • 8[8]Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus[J]. Lupus,2000, 9 (5):338.
  • 9[9]Cailes J, Winter S, du Bois RM, et al. Defective endothelially mediated pulmonary vasodilation in systemic sclerosis[J]. Chest, 1998,114 ( 1 ):178.
  • 10[10]Varga J. Pulmonary hypertension in systemic sclerosis: Bete Noire No More[J]? Curr Opin R heumatol,2002,14(6): 666.

共引文献82

同被引文献105

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部